Europe Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, and Other Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Country

Publication Month: Aug 2020 | Report Code: TIPRE00013298 | No. of Pages: 105 | Category: Pharmaceuticals | Status: Published
Covid

The Chronic Cough market in Europe is expected to grow from US$ 1,647.94 million in 2019 to US$ 2,881.55 million by 2027. This represents a CAGR of 7.3% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the Europe n chronic cough market during the forecast period.

 

The UK has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in Europe during the forecast period. Cough is an essential neurally mediated reflex that has evolved to protect the upper airways from obstruction and to expel chemical and mechanical irritants. However, when heightened or persistent, cough presents a clinically challenging source of considerable physical and psychological morbidity. Acute cough contributes to approximately 34.0 million working days lost each year in the UK through minor illnesses, with more than £100 million being spent on over-the-counter antitussive drugs each year. A recent survey, conducted across 29 different European countries, found that most subjects with chronic cough responded that their cough medication had limited or no effectiveness (57% and 36%, respectively), with only 7% reporting that medications they had tried for their cough were effective. This lack of effective treatment reflects the need for new treatment. Indeed, it is increasingly recognized that to treat cough syndromes effectively; there is a need to look beyond the presence of underlying disease processes, and towards a better understanding of physiological control of the cough reflex itself.

 

UK Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

UK Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :


 

EUROPE CHRONIC COUGH – MARKET SEGMENTATION

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Other Drug Class

By Route of Administration

  • Oral
  • Injections
  • Nasal
  • Other Route of Administration

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Company Profiles

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1          Chronic Cough Market – By Drug Class

1.3.2          Chronic Cough Market – By Route of Administration

1.3.3          Chronic Cough Market – By Distribution Channel

1.3.4          Europe Chronic Cough Market – By Country

2.          Chronic Cough Market – Key Takeaways

3.          Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.          Chronic Cough Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.          Chronic Cough Market – Key Market Dynamics

5.1         Market Drivers

5.1.1          Rising Incidences of Chronic Cough

5.1.2          Growing Product Developments to Treat Chronic Cough

5.2         Market Restraints

5.2.1          Product Recalls

5.3         Market Opportunities

5.3.1          Aging Population is Expected to Drive Demand for Chronic Cough Treatment

5.4         Future Trends

5.4.1          Continuous Trend of Drug Development

5.5         Impact Analysis

6.          Chronic Cough Market Analysis – By Drug Class

6.1         Overview

6.2         Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

6.3         Antihistamines

6.3.1          Overview

6.3.2          Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.4         Corticosteroids

6.4.1          Overview

6.4.2          Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.5         Decongestants

6.5.1          Overview

6.5.2          Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.6         Combination Drug

6.6.1          Overview

6.6.2          Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.7         Antibiotics

6.7.1          Overview

6.7.2          Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.8         Acid Blockers

6.8.1          Overview

6.8.2          Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.9         Other Drug Class

6.9.1          Overview

6.9.2          Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.          Chronic Cough Market – By Route of Administration

7.1         Overview

7.2         Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

7.3         Oral

7.3.1          Overview

7.3.2          Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Injections

7.4.1          Overview

7.4.2          Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Inhalation

7.5.1          Overview

7.5.2          Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Other Route of Administration

7.6.1          Overview

7.6.2          Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.          Chronic Cough Market – By Distribution Channel

8.1         Overview

8.2         Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacy

8.3.1          Overview

8.3.2          Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Online Pharmacy

8.4.1          Overview

8.4.2          Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Retail Pharmacy

8.5.1          Overview

8.5.2          Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

9.          Chronic Cough Market – Regional Analysis

9.1         Europe: Chronic Cough Market

9.1.1          Overview

9.1.2          Europe: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)

9.1.3          Europe: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.4          Europe: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.5          Europe: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.6          Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)

9.1.7          Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1            Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2            Germany: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.7.3            Germany: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.7.4            Germany: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.8          UK: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1            UK: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2            UK: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.8.3            UK: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.9          France: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1            France: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2            France: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.9.3            France: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.9.4            France: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.10       Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1          Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2          Spain: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.10.3          Spain: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.10.4          Spain: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.11       Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.1          Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.2          Italy: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.11.3          Italy: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.11.4          Italy: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Regional Chronic cough Market

10.1       Europe: Impact Assessment Of COVID-19 Pandemic

11.       COMPANY PROFILES

11.1       Novartis AG

11.1.1       Key Facts

11.1.2       Business Description

11.1.3       Products and Services

11.1.4       Financial Overview

11.1.5       SWOT Analysis

11.1.6       Key Developments

11.2       TEVA PHARMACEUTICAL INDUSTRIES LTD

11.2.1       Key Facts

11.2.2       Business Description

11.2.3       Products and Services

11.2.4       Financial Overview

11.2.5       SWOT Analysis

11.2.6       Key Developments

11.3       GlaxoSmithKline plc.

11.3.1       Key Facts

11.3.2       Business Description

11.3.3       Products and Services

11.3.4       Financial Overview

11.3.5       SWOT Analysis

11.3.6       Key Developments

11.4       Bayer AG

11.4.1       Key Facts

11.4.2       Business Description

11.4.3       Products and Services

11.4.4       Financial Overview

11.4.5       SWOT Analysis

11.4.6       Key Developments

11.5       MYLAN N.V.

11.5.1       Key Facts

11.5.2       Business Description

11.5.3       Products and Services

11.5.4       Financial Overview

11.5.5       SWOT Analysis

11.5.6       Key Developments

11.6       Amneal Pharmaceuticals, Inc.

11.6.1       Key Facts

11.6.2       Business Description

11.6.3       Products and Services

11.6.4       Financial Overview

11.6.5       SWOT Analysis

11.6.6       Key Developments

11.7       Cipla Inc.

11.7.1       Key Facts

11.7.2       Business Description

11.7.3       Products and Services

11.7.4       Financial Overview

11.7.5       SWOT Analysis

11.7.6       Key Developments

11.8       Reckitt Benckiser Group plc.

11.8.1       Key Facts

11.8.2       Business Description

11.8.3       Products and Services

11.8.4       Financial Overview

11.8.5       SWOT Analysis

11.8.6       Key Developments

11.9       Sun Pharmaceutical Industries Ltd

11.9.1       Key Facts

11.9.2       Business Description

11.9.3       Products and Services

11.9.4       Financial Overview

11.9.5       SWOT Analysis

11.9.6       Key Developments

11.10     Aurobindo Pharma Ltd

11.10.1     Key Facts

11.10.2     Business Description

11.10.3     Products and Services

11.10.4     Financial Overview

11.10.5     SWOT Analysis

11.10.6     Key Developments

12.       Appendix

12.1       Glossary of Terms

 

LIST OF TABLES

Table 1.             Europe Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 9.             UK Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.           France Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.           France Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 12.           France Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13.           Spain Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.           Spain Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 15.           Spain Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 16.           Italy Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 17.           Italy Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 18.           Italy Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 19.           Glossary of Terms, Chronic Cough Market

 

LIST OF FIGURES

Figure 1.            Chronic Cough Market Segmentation

Figure 2.            Chronic Cough Market – By Country

Figure 3.            Europe Chronic Cough Market Overview

Figure 4.            Combination Drug Segment Held Largest Share of Chronic Cough Market

Figure 5.            UK to Show Remarkable Growth During Forecast Period

Figure 6.            Europe PEST Analysis

Figure 7.            Expert Opinion

Figure 8.            Chronic Cough Market Impact Analysis of Drivers and Restraints

Figure 9.            Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

Figure 10.          Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.          Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.          Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.          Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.          Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.          Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.          Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.          Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

Figure 18.          Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.          Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.          Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.          Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.          Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

Figure 23.          Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.          Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.          Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.          Europe: Chronic Cough Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.          Europe Chronic Cough Market Revenue and Forecast to 2027 (USD Million)

Figure 28.          Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)

Figure 29.          Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.          UK: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.          France: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.          Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.          Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.          Impact of COVID-19 Pandemic in European Country Markets

 

 

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. GlaxoSmithKline plc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. Aurobindo Pharma Ltd
  • To understand the Europe chronic cough market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Europe Chronic Cough market
  • To efficiently plan M&A and partnership deals in the Europe chronic cough market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe chronic cough market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Europe chronic cough market
TIPRE00013298
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing